Time Magazine editors recently highlighted the Best Inventions of 2024.

To compile this year’s list, the magazine solicited nominations from Time’s editors and correspondents around the world, and through an online application process and evaluated each contender on originality, efficacy, ambition, and impact.

Some of the winners in the beauty and skin health categories include:

Plated Skin Science’s Intense Serum

Plated Skin Science‘s Intense Serum, the first skincare serum to use platelet-derived exosomes. The serum contains more than 1 trillion exosomes per bottle (up to 15 billion in every pump), and regular use improves the appearance of tone, texture, and fine lines and wrinkles, for youthful, radiant-looking skin and reducing visible signs of aging.

“Plated is so honored to receive this recognition from Time magazine,” says Plated Skin Science and Rion Aesthetics CEO Alisa Lask, in a news release. “This is a testament to the physician-scientists who brought this technology to life, and to the aesthetic physicians and providers who have been instrumental to our success. This recognition reinforces our commitment to advancing innovative solutions that truly elevate skincare.”

Plated’s parent company Rion was founded by Mayo Clinic physician-scientists at the Van Cleve Cardiac Regenerative Medicine Program. The company now produces regenerative platelet-derived exosomes, currently in clinical trials for wound healing, cardiology and orthopedics, while its spinoff – Plated Skin Science – focuses on aesthetic applications.

Plated Intense Serum is found in dermatologist and plastic surgeon offices nationwide, and online at PlatedSkinScience.com.

DermaSensor

The U.S Food and Drug Administration (FDA) cleared DermaSensor for skin cancer detection in primary care in 2024.

Wireless and handheld, DermaSensor’s AI-powered spectroscopy technology non-invasively evaluates cellular and subcellular characteristics of a lesion, providing an immediate and objective result using an FDA-cleared algorithm.  The FDA pivotal study of more than 1,000 patients, showed that the device had a sensitivity of 96% across all 224 skin cancers. A negative result had a 97% chance of being benign for all skin cancers. In a companion clinical utility study with 108 physicians, the DermaSensor device was found to decrease the number of missed skin cancers by half (from 18% to only 9%), increasing the physicians’ accuracy and confidence in assessing cancerous lesions.

NuFace’s Trinity+ Complete

NuFace’s Trinity+ Complete, a handheld facial toning device combines microcurrent and red light therapy to tighten facial muscles and smooth wrinkles.

See the full list of Time Best Inventions for 2024 here.